Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action

Area of Science:

• Neuroscience
• Molecular Psychiatry
• Pharmacology

Background:

• Neurotrophic factors, especially brain-derived neurotrophic factor (BDNF), are implicated in depression.
• Impaired BDNF signaling via its receptor TrkB has been linked to mood disorder pathophysiology, though recent meta-analyses show mixed results.
• Further research is needed to clarify the role of BDNF in mood disorders.

Purpose of the Study:

• To review and synthesize recent evidence on the role of BDNF and neuronal plasticity in mood disorders.
• To elucidate the mechanisms by which antidepressants regulate BDNF signaling.
• To strengthen the hypothesis connecting neurotrophic factors and plasticity to antidepressant action.

Main Methods:

• Review of preclinical and clinical studies.
• Analysis of meta-analyses findings.
• Synthesis of recent research data on BDNF signaling and neuronal plasticity.

Main Results:

• Increased BDNF expression and signaling are consistently implicated in the action of both typical and rapid-acting antidepressants.
• Antidepressants appear to regulate BDNF signaling through specific mechanisms.
• BDNF is a key regulator of neuronal plasticity, which is increasingly linked to antidepressant effects.

Conclusions:

• Converging evidence supports a connection between neurotrophic factors, neuronal plasticity, mood disorders, and antidepressant action.
• Despite some equivocal data, recent findings strengthen the neurotrophic hypothesis of depression and antidepressant efficacy.
• Understanding BDNF regulation by antidepressants may lead to novel therapeutic strategies for mood disorders.